Soichi Takeda
Overview
Explore the profile of Soichi Takeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaji K, Takeda S, Iwai S, Nishimura N, Sato S, Namisaki T, et al.
Antioxidants (Basel)
. 2024 Nov;
13(11).
PMID: 39594556
Imeglimin promotes glucose-stimulated insulin secretion in the pancreas in a glucose-dependent manner and inhibits gluconeogenesis in the liver. Meanwhile, imeglimin can improve mitochondrial function in hepatocytes. We used a nondiabetic...
2.
Ishiyama H, Kim H, Saito S, Takeda S, Takegami M, Yamamoto Y, et al.
Ann Neurol
. 2024 Mar;
95(6):1040-1054.
PMID: 38520151
Objectives: Intracerebral hemorrhage (ICH) and cerebral microbleeds (CMB) in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy are more common in East Asian populations than in people of white...
3.
Suzuki J, Namisaki T, Takya H, Kaji K, Nishimura N, Shibamoto A, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473925
Portal vein thrombosis (PVT), one of the most prevalent hepatic vascular conditions in patients with liver cirrhosis (LC), is associated with high mortality rates. An imbalance between a disintegrin-like metalloproteinase...
4.
Asada S, Namisaki T, Kaji K, Takaya H, Kubo T, Akahane T, et al.
Dig Dis Sci
. 2024 Jan;
69(3):851-869.
PMID: 38244124
Aim: We investigated the von Willebrand factor to ADAMTS13 ratio (von Willebrand factor [VWF]:Ag/ADAMTS13:AC) as a potential biomarker for the outcomes of acute kidney injury (AKI) in liver cirrhosis (LC)....
5.
Iwasa T, Urasaki A, Kakihana Y, Nagata-Akaho N, Harada Y, Takeda S, et al.
J Clin Med
. 2023 Aug;
12(15).
PMID: 37568404
Hereditary hemorrhagic telangiectasia (HHT) is a vascular disease caused by the defects of ALK1/ACVRL1 receptor signaling. In this study, we evaluated 25 recently identified ACVRL1 missense variants using multiple computational...
6.
Shibamoto A, Namisaki T, Suzuki J, Kubo T, Iwai S, Tomooka F, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443613
Alcohol is a major risk factor of liver cirrhosis (LC). This study aimed to elucidate a surrogate marker of sarcopenia in patients with LC of different etiology. Out of 775...
7.
Yorioka N, Namisaki T, Shibamoto A, Suzuki J, Kubo T, Iwai S, et al.
In Vivo
. 2023 Apr;
37(3):1226-1235.
PMID: 37103093
Background/aim: The management of refractory ascites is critical for the treatment of patients with decompensated cirrhosis. This study aimed to evaluate the feasibility and safety of cell-free and concentrated ascites...
8.
Shibamoto A, Namisaki T, Suzuki J, Kubo T, Iwai S, Tomooka F, et al.
Hepatol Res
. 2023 Apr;
53(8):713-722.
PMID: 37050844
Aim: This study aimed to elucidate a surrogate marker of sarcopenia in patients with liver cirrhosis (LC). Methods: A total of 424 patients were assessed for handgrip strength (HGS) and...
9.
Kitagawa K, Mitoro A, Tomooka F, Asada S, Fujinaga Y, Nishimura N, et al.
DEN Open
. 2022 Oct;
3(1):e177.
PMID: 36304177
Objectives: Serial pancreatic juice aspiration cytological examination (SPACE) via endoscopic retrograde cholangiopancreatography is a useful diagnostic method for early-stage pancreatic cancer, such as carcinoma in situ that are difficult to...
10.
Takeda S, Namisaki T, Tsuji Y, Fujimoto Y, Murata K, Enomoto M, et al.
Anticancer Res
. 2022 Oct;
42(11):5465-5473.
PMID: 36288892
Background/aim: The current study evaluated the efficacy and toxicity of atezolizumab plus bevacizumab in patients with advanced-stage hepatocellular carcinoma in a real-world setting. Patients And Methods: This retrospective study enrolled...